Skip to main content
Premium Trial:

Request an Annual Quote

Theodor Dingermann

Premium

Protagen this week appointed Theodor Dingermann to its supervisory board. Dingermann is managing director of the Institute for Pharmaceutical Biology at the Johann Wolfgang Goethe-University. His appointment fills the sixth position on Protagen’s board as required by German law. Dingermann is also on the supervisory board of Innovectis.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.